11:53 AM EDT, 03/25/2024 (MT Newswires) -- Price: 41.42, Change: +4.48, Percent Change: +12.12 ...

11:48 AM EDT, 03/25/2024 (MT Newswires) -- Rhythm Pharmaceuticals ( RYTM ) said Monday that the first patients were dosed in the phase 1 trial of RM-718 to treat obesity. RM-718 is a weekly melanocortin-4 receptor-specific agonist that has demonstrated the potential to reduce body weight and hunger in preclinical studies, the company said. The three-part study will evaluate the...

11:46 AM EDT, 03/25/2024 (MT Newswires) -- (Updates with Regeneron's response in the third paragraph and the latest stock move of Intellia and Regeneron in the fifth paragraph.) Intellia Therapeutics ( NTLA ) said in a Friday filing that it has decided to end its 2020 agreement with Regeneron Pharmaceuticals ( REGN ) on developing gene editing products directed to...

11:45 AM EDT, 03/25/2024 (MT Newswires) -- BigCommerce Holdings ( BIGC ) revenue growth outlook is uninspiring amid tough competition and macro, BofA Securities said in a note Monday. Revenue growth is crucial in this sector, and the company is expected to see a revenue growth rate of 5.7% in 2024, which is lower than the industry average, analyst Koji...